These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21702715)

  • 1. Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010).
    Sun S; McKenna CE
    Expert Opin Ther Pat; 2011 Sep; 21(9):1433-51. PubMed ID: 21702715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase.
    Rodriguez JB; Falcone BN; Szajnman SH
    Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and characterization of non-bisphosphonate quinoline derivatives as new FPPS inhibitors.
    Liu J; Liu W; Ge H; Gao J; He Q; Su L; Xu J; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Mar; 1840(3):1051-62. PubMed ID: 24246954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.
    Marzinzik AL; Amstutz R; Bold G; Bourgier E; Cotesta S; Glickman JF; Götte M; Henry C; Lehmann S; Hartwieg JC; Ofner S; Pellé X; Roddy TP; Rondeau JM; Stauffer F; Stout SJ; Widmer A; Zimmermann J; Zoller T; Jahnke W
    ChemMedChem; 2015 Nov; 10(11):1884-91. PubMed ID: 26381451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
    Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
    Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
    Räikkönen J; Taskinen M; Dunford JE; Mönkkönen H; Auriola S; Mönkkönen J
    Biochem Biophys Res Commun; 2011 Apr; 407(4):663-7. PubMed ID: 21420384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
    Kavanagh KL; Guo K; Dunford JE; Wu X; Knapp S; Ebetino FH; Rogers MJ; Russell RG; Oppermann U
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7829-34. PubMed ID: 16684881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.
    Ohno K; Mori K; Orita M; Takeuchi M
    Curr Med Chem; 2011; 18(2):220-33. PubMed ID: 21110804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors.
    Liu Q; Miao Y; Wang X; Lv G; Peng Y; Li K; Li M; Qiu L; Lin J
    Eur J Med Chem; 2020 Jan; 186():111905. PubMed ID: 31785819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.
    Jahnke W; Rondeau JM; Cotesta S; Marzinzik A; Pellé X; Geiser M; Strauss A; Götte M; Bitsch F; Hemmig R; Henry C; Lehmann S; Glickman JF; Roddy TP; Stout SJ; Green JR
    Nat Chem Biol; 2010 Sep; 6(9):660-6. PubMed ID: 20711197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.
    Ebetino FH; Sun S; Cherian P; Roshandel S; Neighbors JD; Hu E; Dunford JE; Sedghizadeh PP; McKenna CE; Srinivasan V; Boeckman RK; Russell RGG
    Bone; 2022 Mar; 156():116289. PubMed ID: 34896359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity.
    Grimaldi M; Randino R; Ciaglia E; Scrima M; Buonocore M; Stillitano I; Abate M; Covelli V; Tosco A; Gazzerro P; Bifulco M; Rodriquez M; D'Ursi AM
    Bioorg Chem; 2020 May; 98():103449. PubMed ID: 32057422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.
    Aripirala S; Gonzalez-Pacanowska D; Oldfield E; Kaiser M; Amzel LM; Gabelli SB
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):802-10. PubMed ID: 24598749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.
    Das S; Edwards PA; Crockett JC; Rogers MJ
    Biochim Biophys Acta; 2014 Apr; 1841(4):569-73. PubMed ID: 24369118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
    Todenhöfer T; Hennenlotter J; Kühs U; Gerber V; Gakis G; Vogel U; Aufderklamm S; Merseburger A; Knapp J; Stenzl A; Schwentner C
    World J Urol; 2013 Apr; 31(2):345-50. PubMed ID: 22407328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the N-BP Binding at FPPS by Combined Computational Approaches.
    Stefanucci A; Marrone A; Agamennone M
    Med Chem; 2015; 11(5):417-31. PubMed ID: 25541745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
    J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patent review of bisphosphonates in treating bone disease.
    Holstein SA
    Expert Opin Ther Pat; 2019 May; 29(5):315-325. PubMed ID: 31023104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights about the structure of farnesyl diphosphate synthase (FPPS) and the activity of bisphosphonates on the proliferation and ultrastructure of Leishmania and Giardia.
    Gadelha APR; Brigagao CM; da Silva MB; Rodrigues ABM; Guimarães ACR; Paiva F; de Souza W; Henriques C
    Parasit Vectors; 2020 Apr; 13(1):168. PubMed ID: 32248823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.